Discontinued — last reported Q1 '18
KLA Corporation Allowance for Doubtful Accounts Receivable (Current) decreased by 1.2% to $33.96M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 11.3%, from $30.50M to $33.96M. Over 4 years (FY 2021 to FY 2025), Allowance for Doubtful Accounts Receivable (Current) shows an upward trend with a 17.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
A significant increase relative to receivables may signal deteriorating customer credit quality or economic headwinds in specific markets.
This is a contra-asset account representing the estimated amount of accounts receivable that the company expects will no...
Standard across all industries; peers in the medical device sector typically maintain low levels unless operating in high-risk emerging markets.
allowance_for_doubtful_accounts_receivable_current| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $18.04M | $17.89M | $19.36M | $19.04M | $20.63M | $27.01M | $34.48M | $33.12M | $33.63M | $33.53M | $35.42M | $33.62M | $32.78M | $32.62M | $30.50M | $31.52M | $34.02M | $34.37M | $33.96M |
| QoQ Change | — | -0.8% | +8.2% | -1.7% | +8.4% | +30.9% | +27.7% | -3.9% | +1.5% | -0.3% | +5.6% | -5.1% | -2.5% | -0.5% | -6.5% | +3.3% | +7.9% | +1.0% | -1.2% |
| YoY Change | — | — | — | — | +14.4% | +50.9% | +78.1% | +74.0% | +63.0% | +24.2% | +2.7% | +1.5% | -2.5% | -2.7% | -13.9% | -6.2% | +3.8% | +5.4% | +11.3% |
We use cookies for analytics. See our Privacy and Cookie Policy.